Premium
The identification of plant lectins with mucosal adjuvant activity
Author(s) -
Lavelle E. C.,
Grant G.,
Pusztai A.,
Pfüller U.,
O'hagan D. T.
Publication year - 2001
Publication title -
immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.297
H-Index - 133
eISSN - 1365-2567
pISSN - 0019-2805
DOI - 10.1046/j.1365-2567.2001.01157.x
Subject(s) - adjuvant , lectin , ovalbumin , immunogenicity , cholera toxin , agglutinin , biology , c type lectin , antigen , wheat germ agglutinin , immunology , antibody , microbiology and biotechnology
Summary To date, the most potent mucosal vaccine adjuvants to be identified have been bacterial toxins. The present data demonstrate that the type 2 ribosome‐inactivating protein (type 2 RIP), mistletoe lectin I (ML‐I) is a strong mucosal adjuvant of plant origin. A number of plant lectins were investigated as intranasal (i.n.) coadjuvants for a bystander protein, ovalbumin (OVA). As a positive control, a potent mucosal adjuvant, cholera toxin (CT), was used. Co‐administration of ML‐I or CT with OVA stimulated high titres of OVA‐specific serum immunoglobulin G (IgG) in addition to OVA‐specific IgA in mucosal secretions. CT and ML‐I were also strongly immunogenic, inducing high titres of specific serum IgG and specific IgA at mucosal sites. None of the other plant lectins investigated significantly boosted the response to co‐administered OVA. Immunization with phytohaemagglutinin (PHA) plus OVA elicited a lectin‐specific response but did not stimulate an enhanced response to OVA compared with the antigen alone. Intranasal delivery of tomato lectin (LEA) elicited a strong lectin‐specific systemic and mucosal antibody response but only weakly potentiated the response to co‐delivered OVA. In contrast, administration of wheatgerm agglutinin (WGA) or Ulex europaeus lectin 1 (UEA‐I) with OVA stimulated a serum IgG response to OVA while the lectin‐specific responses (particularly for WGA) were relatively low. Thus, there was not a direct correlation between immunogenicity and adjuvanticity although the strongest adjuvants (CT, ML‐I) were also highly immunogenic.